Important pharmacy news and late-breaking industry information updated daily.
New study raises a red flag about appropriate antibiotic use
Drug manufacturers have sharply increased prices of some older, low-cost prescription medicines amid supply shortages and recalls. For example, at least three sellers of the widely used blood-pressure medication valsartan have raised prices since a series of safety-related recalls of the drug by other manufacturers began in the summer of 2018.
FDA has approved the first generic version of the anti-seizure medication vigabatrin (Sabril—Lundbeck).
New and emerging considerations in Parkinson’s disease
Walmart reported Tuesday that it will no longer honor prescription drug coverage from CVS Health, leaving large numbers of Walmart customers searching for a new pharmacist. The move affects Walmart customers with CVS Caremark pharmacy coverage through employer-sponsored insurance and state Medicaid managed-care plans.
The law sets the stage for direct relationships with payers
New study says select patients with COPD phenotypes likely to respond to triple therapy
House Oversight and Reform Committee Chairman Elijah Cummings (D-MD) sent letters to 12 different drug companies seeking detailed information and documents about how the companies price their medications. The request is part of a new sweeping investigation into the industry's pricing practices.
Recommendations include combining two types of laxatives from different classes before escalating therapy
Between 6.2 million and 7.3 million people in the United States have been sick with influenza so far this season, CDC reported Friday. According to new data, 2.9 million to 3.5 million people have visited the doctor because of influenza, and up to 83,500 people have been hospitalized because of influenza.